Literature DB >> 35887403

Correction: Yu et al. HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. Int. J. Mol. Sci. 2022, 23, 4943.

Lulu Yu1, Vladimir Majerciak1, Zhi-Ming Zheng1.   

Abstract

In the published review [...].

Entities:  

Year:  2022        PMID: 35887403      PMCID: PMC9320314          DOI: 10.3390/ijms23147903

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


In the published review [1], the HPV16 late promoter PL in Figure 1a was wrongly labeled in the E6 open reading frame. The corrected Figure 1a below shows the HPV16 PL promoter in the E7 open reading frame.
Figure 1

Papillomavirus genome structure, annotated ORFs, and conserved ACS in the origin of replication (Ori). (a) HPV16 genome and annotated ORFs. The non-structural proteins from the early region of the genome, including E1, E2, E1^E4, E5, E6, E7, and E8^E2, are shown in purple. The viral capsid proteins, L1 and L2, from the late region of the genome are shown in blue. URR (yellow), upstream regulatory region. PE and PL mark the early and late promoters, and pAE and pAL stand for the early and late polyadenylation sites. (b) Conservation of the mammalian ARS consensus sequence (ACS) [16] in the Ori of selected papillomavirus genomes. Shown in this panel are conserved bases with position weight matrix (sequence logo bits) of the 167 predicted ACS elements [16] in comparison with the viral Ori sequences from the selected viral URR tail (red)-head (black) regions. Adapted with permission from Ref. [16]. Copyright 2018 Springer Nature. ARS—autonomously replicating sequence.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
  1 in total

Review 1.  HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.

Authors:  Lulu Yu; Vladimir Majerciak; Zhi-Ming Zheng
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.